IAB-201

N/A

Report date: 2022/08/09 18:04:50

Base Information

Drug NameIAB-201

Drug Alias NameIAB-201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionVascular endothelial growth factor inhibitors

TargetsVascular endothelial growth factor

Therapy Area/IndicationsDiabetic Retinopathy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesImmunAbs Inc

China Registration ClassN/A

Active CompaniesImmunAbs Inc

Inactive CompaniesN/A

Active IndicationsDiabetic Retinopathy

Inactive IndicationsN/A

ATC CodeN/A